Calcium Oxybate

CHEMBL4594393 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
246.3 g/mol
LogP
Phase
4

A calcium-containing formulation of gamma-hydroxybutyrate (GHB), under investigation as a treatment for narcolepsy, a sleep disorder causing excessive daytime sleepiness and cataplexy. It works on GABA and GHB receptors in the brain to consolidate nighttime sleep. It has a lower sodium content compared to sodium oxybate, which may benefit patients on sodium-restricted diets.

Moleküler Ağırlık

246,2700 g/mol

TPSA

121,00 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C([O-])CCCO.O=C([O-])CCCO.[Ca+2]

InChI

InChI=1S/2C4H8O3.Ca/c2*5-3-1-2-4(6)7;/h2*5H,1-3H2,(H,6,7);/q;;+2/p-2

Molecular Formula

C8H14CaO6

HBD / HBA

2 / 6

Döndürülebilir Bağlar

4

Ağır Atomlar

15

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A calcium-containing formulation of gamma-hydroxybutyrate (GHB), under investigation as a treatment for narcolepsy, a sleep disorder causing excessive daytime sleepiness and cataplexy. It works on GABA and GHB receptors in the brain to consolidate nighttime sleep. It has a lower sodium content compared to sodium oxybate, which may benefit patients on sodium-restricted diets.

Yes, Calcium Oxybate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4594393. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 6100372. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.